Shiqin Li - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shiqin Li

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Exploration (Beijing, China)|June 10, 2024

From structural design to delivery: mRNA therapeutics for cancer immunotherapyFeng Zhou, Lujia Huang, Shiqin Li, et al.

Molecular Cancer|May 7, 2022

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinomaAshuai Du, Shiqin Li, Yuzheng Zhou, et al.

The Journal of Biological Chemistry|January 15, 2022

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradationYuzheng Zhou, Rong Zheng, Sixu Liu, et al.

International Journal of Biological Macromolecules|February 6, 2021

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2Ashuai Du, Rong Zheng, Cyrollah Disoma, et al.

Journal of Virology|August 18, 2022

UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4bYuzheng Zhou, Rong Zheng, Donglan Liu, et al.

Frontiers in Microbiology|October 28, 2021

Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut MicrobiotaSijia Li, Siyuan Yang, Yuzheng Zhou, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Exploration (Beijing, China)|June 10, 2024

From structural design to delivery: mRNA therapeutics for cancer immunotherapyFeng Zhou, Lujia Huang, Shiqin Li, et al.

Molecular Cancer|May 7, 2022

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinomaAshuai Du, Shiqin Li, Yuzheng Zhou, et al.

The Journal of Biological Chemistry|January 15, 2022

Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradationYuzheng Zhou, Rong Zheng, Sixu Liu, et al.

International Journal of Biological Macromolecules|February 6, 2021

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2Ashuai Du, Rong Zheng, Cyrollah Disoma, et al.

Journal of Virology|August 18, 2022

UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4bYuzheng Zhou, Rong Zheng, Donglan Liu, et al.

Frontiers in Microbiology|October 28, 2021

Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut MicrobiotaSijia Li, Siyuan Yang, Yuzheng Zhou, et al.

Pageof 6